WhoshouldIsee Tracks

Leading Executive Search for Pharma & Life Sciences | Parsity Group

Tom Foster

Polpharma Biologics – Case Study

How Parsity Group navigated a niche talent pool to secure a CTO during a critical organisation change THE BRIEF The client had recently undergone a strategic shift, segmenting its CDMO activities from its Biosimilars development & commercialization. With operations relocating to Switzerland, the business faced a “leadership vacuum” at a pivotal moment. The Risk: Without

Polpharma Biologics – Case Study Read More »

The Private Equity Catalyst: Reshaping the Generics and Biosimilar Industry

Why the Generics and Biosimilar Market is Redefining Private Equity Success For years, the generics and biosimilar industries have been defined by stability and volume—a reliable but low-margin foundation. Today, Private Equity (PE) is transforming this narrative, moving beyond traditional financial engineering to become a primary force for operational excellence and unprecedented value creation. This

The Private Equity Catalyst: Reshaping the Generics and Biosimilar Industry Read More »

How AI is Transforming Executive Search

AI technology is reshaping the executive search industry by enhancing efficiency in daily tasks, allowing search professionals to focus on building relationships and engaging with clients and candidates. Properly used, AI can streamline processes and improve time management without sacrificing the personal touch essential for effective executive placements. AI’s capabilities complement human expertise, but cannot

How AI is Transforming Executive Search Read More »

Top Leadership Qualities Driving Innovation in the Generics and Biosimilars Sector

As the generics and biosimilars industry grows, the demand for visionary and adaptable leadership has never been greater. Executives in this industry must possess a unique set of qualities to navigate complex regulatory environments, drive innovation, and ensure sustainable growth. Here are the top leadership qualities that are essential for success in the generics and

Top Leadership Qualities Driving Innovation in the Generics and Biosimilars Sector Read More »

How to Build a Leadership Talent Pipeline

Building a strong leadership pipeline in the generics industry is essential for ensuring sustained growth and competitiveness. The generics market faces unique challenges, such as pricing pressures, regulatory scrutiny, and the need for continuous innovation. To navigate these complexities, companies must focus on developing future leaders who can drive success. 1. Identify High-Potential Talent Early

How to Build a Leadership Talent Pipeline Read More »

Mid-Year Executive Talent Outlook Report 2025

As we pass the halfway point of 2025, our latest report offers a deep dive into the key market dynamics, M&A trends, and evolving leadership demands shaping the sector.  This report provides critical insights into the shift towards complex products, the growing influence of private equity, and the essential leadership qualities needed to thrive in

Mid-Year Executive Talent Outlook Report 2025 Read More »

The Underrated Leadership Quality: What Pharma Really Values in 2025

In a recent poll conducted by Parsity Group, we asked our network a simple but powerful question: “What’s the most underrated leadership quality essential for success in pharma today?” The results were revealing and may surprise some: Emotional Intelligence / Empathy – 52% Resilience & Adaptability – 25% Cross-functional Collaboration – 20% Digital Fluency /

The Underrated Leadership Quality: What Pharma Really Values in 2025 Read More »

Why Senior Leaders Should Consider a Career in the Generics and Biosimilars Sector

For senior pharmaceutical leaders, deciding to make the move into the generics and biosimilars sector can be a hugely rewarding step in their careers. It’s a sector filled with unique opportunities, from making a direct and measurable impact on global patient care to navigating a fast-paced, agile environment that contrasts with other industry sectors, both

Why Senior Leaders Should Consider a Career in the Generics and Biosimilars Sector Read More »

Should you hire

Should You Hire Someone Like You or Someone Who Challenges You?

When it comes to building an executive team, many leaders instinctively gravitate toward candidates who “feel like a good fit.” They speak the same language, share similar backgrounds, and often seem like a natural extension of the leader themselves. It feels comfortable and predictable. But is that always the best move? From an executive leadership

Should You Hire Someone Like You or Someone Who Challenges You? Read More »